• JBM shifted leadership of its nomination committee, effective Aug. 10, 2026.
• Chairman and CEO Derek Sum Kwong Yip resigned as nomination committee chair.
• Independent non-executive director Alan Luk Ting Lung, previously a nomination committee member, was appointed chair.
• Independent non-executive director Simon Chan Kam Chiu stepped down from the remuneration committee and the nomination committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JBM (Healthcare) Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260810-12278825), on August 10, 2026, and is solely responsible for the information contained therein.